381 related articles for article (PubMed ID: 35216283)
1. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.
Korbecki J; Kupnicka P; Chlubek M; Gorący J; Gutowska I; Baranowska-Bosiacka I
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216283
[TBL] [Abstract][Full Text] [Related]
2. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
Dong YL; Kabir SM; Lee ES; Son DS
PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
[TBL] [Abstract][Full Text] [Related]
3. Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization.
Boon K; Vanalken N; Szpakowska M; Chevigné A; Schols D; Van Loy T
Cell Commun Signal; 2024 Jan; 22(1):43. PubMed ID: 38233929
[TBL] [Abstract][Full Text] [Related]
4. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
5. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.
Kershaw MH; Wang G; Westwood JA; Pachynski RK; Tiffany HL; Marincola FM; Wang E; Young HA; Murphy PM; Hwu P
Hum Gene Ther; 2002 Nov; 13(16):1971-80. PubMed ID: 12427307
[TBL] [Abstract][Full Text] [Related]
6. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
[TBL] [Abstract][Full Text] [Related]
7. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
8. High content screening of CXCR2-dependent signalling pathways.
Wolff M; Kredel S; Haasen D; Wiedenmann J; Nienhaus GU; Kistler B; Oswald F; Heilker R
Comb Chem High Throughput Screen; 2010 Jan; 13(1):3-15. PubMed ID: 20214572
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8: An evolving chemokine.
Matsushima K; Yang D; Oppenheim JJ
Cytokine; 2022 May; 153():155828. PubMed ID: 35247648
[TBL] [Abstract][Full Text] [Related]
10. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis.
Zhou Z; Xia G; Xiang Z; Liu M; Wei Z; Yan J; Chen W; Zhu J; Awasthi N; Sun X; Fung KM; He Y; Li M; Zhang C
Clin Cancer Res; 2019 Jun; 25(11):3317-3328. PubMed ID: 30796034
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
[TBL] [Abstract][Full Text] [Related]
12. A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: regulatory effects of pro-inflammatory cytokines.
Lisi S; Sisto M; Lofrumento DD; D'Amore M; De Lucro R; Ribatti D
Histochem Cell Biol; 2013 Feb; 139(2):371-9. PubMed ID: 23052840
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer.
Lee CH; Syu SH; Liu KJ; Chu PY; Yang WC; Lin P; Shieh WY
Oncotarget; 2015 Nov; 6(36):38866-80. PubMed ID: 26462152
[TBL] [Abstract][Full Text] [Related]
14. CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma.
Kasashima H; Yashiro M; Nakamae H; Kitayama K; Masuda G; Kinoshita H; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
Am J Pathol; 2016 Nov; 186(11):3028-3039. PubMed ID: 27742059
[TBL] [Abstract][Full Text] [Related]
15. New insights into ADAMs regulation of the GRO-α/CXCR2 system: focus on Sjögren's syndrome.
Sisto M; Lisi S
Int Rev Immunol; 2015; 34(6):486-99. PubMed ID: 25386842
[TBL] [Abstract][Full Text] [Related]
16. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
17. A role for CXCR2 in senescence, but what about in cancer?
Acosta JC; Gil J
Cancer Res; 2009 Mar; 69(6):2167-70. PubMed ID: 19276354
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.
Raghuwanshi SK; Su Y; Singh V; Haynes K; Richmond A; Richardson RM
J Immunol; 2012 Sep; 189(6):2824-32. PubMed ID: 22869904
[TBL] [Abstract][Full Text] [Related]
19. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
Zaslaver A; Feniger-Barish R; Ben-Baruch A
J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
[TBL] [Abstract][Full Text] [Related]
20. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction.
Yang W; Wang D; Richmond A
J Biol Chem; 1999 Apr; 274(16):11328-33. PubMed ID: 10196223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]